SOLACI-CACI 2021 | Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease

✔️ Watch again the session “Current & Immediate Future Role of Imaging in Structural and Coronary Heart Disease” in the SOLACI-CACI 2021 Congress.

👨‍🏫 Program:

  • 02:27 – Computer Tomography in TAVR: Planning, Predicting Complications, and Follow-up – Mariano Falconi
  • 19:26 – Multi-Imaging Evaluation in Mitral Regurgitation Intervention – Fabián Salmo
  • 31:10 – New Prognosis Tools in Cardiac CT: Beyond Stenosis – Gastón Rodríguez Granillo
  • 48:32 – Understanding Phenotypical Differences Between Genders in Chronic Coronary Syndromes – Roxana Campisi
  • 01:03:20 – Role of Coronary CT for Guiding Complex Procedures: CTO and CHIP – Hector García García

👉🏻 Panelists: Cerda, Miguel – De Quadros, Alexandre S. – Fernández, Mario – Fernández-Pereira, Carlos – Ingino, Carlos – Larraburu, Alfredo – Sciancalepore, Agustina
👉🏻 Chairpersons: Diego Pérez de Arenaza & Aníbal Damonte
👉🏻 Digital Moderator: Marcelo Halac


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

Embolization of Left Atrial Appendage Closure Devices: Predictors, Prevention, and Management Strategies

Atrial fibrillation is associated with an increased risk of stroke and, in patients with contraindications to anticoagulation, percutaneous left atrial appendage closure represents an...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...